TB-500 (5 mg Vial)

TB-500 (5 mg Vial): reconstitution reference for research laboratories. Includes the diluent volume and resulting concentration, syringe-unit conversion, vial and consumable planning, and storage guidance.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
TB-500 (5 mg Vial)

Synonyms/Alias: TB-500

Purity: Specification by inquiry

Custom Peptide Support

  • Sequence, purity and scale confirmation
  • CoA and technical documentation requests
  • API, research and cosmetic peptide options
  • Distributor and institution quotation support

TB-500 (5 mg Vial): reconstitution reference for research laboratories. Includes the diluent volume and resulting concentration, syringe-unit conversion, vial and consumable planning, and storage guidance.

Quickstart

Reconstitute: Add 3.0 mL bacteriostatic water → ~ 1.67 mg/mL concentration.

Typical daily range: 500–1000 mcg once daily (gradual titration recommended).

Easy measuring: At 1.67 mg/mL, 1 unit = 0.01 mL ≈ 16.7 mcg on a U‑100 insulin syringe.

Storage: Lyophilized: store at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); do not freeze reconstituted solution.

Notes

Practical considerations for consistency and safety in research protocols. Use new sterile insulin syringes for each injection; dispose in a sharps container. Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation and lipohypertrophy [9]. Inject slowly; wait a few seconds before withdrawing the needle to prevent backflow. Document daily dose, injection site, and any observations to maintain consistency. Regulatory Note: TB‑500 is banned by WADA for athletic use and is not FDA‑approved for human administration [10].

Single peptide protocol reference: Available for related research, development or formulation inquiry workflows.

Reconstitution and handling reference: Available for related research, development or formulation inquiry workflows.

Research-use documentation inquiry: Available for related research, development or formulation inquiry workflows.

Weeks 1–2
Daily Dose (mcg): 500 mcg | Units (per injection) (mL): 30 units (0.30 mL)
Weeks 3–4
Daily Dose (mcg): 600 mcg | Units (per injection) (mL): 36 units (0.36 mL)
Weeks 5–8
Daily Dose (mcg): 750 mcg | Units (per injection) (mL): 45 units (0.45 mL)
Weeks 9–12
Daily Dose (mcg): 1000 mcg | Units (per injection) (mL): 60 units (0.60 mL)
Long-term Storage Conditions
Lyophilized: store at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); do not freeze reconstituted solution.
Shipping Condition
Shipping conditions by inquiry

Peptide Vials (TB‑500, 5 mg each): 8 weeks ≈ 8 vials

12 weeks ≈ 12 vials

16 weeks ≈ 16 vials

Insulin Syringes (U‑100): Per week: 7 syringes (1/day)

8 weeks: 56 syringes

12 weeks: 84 syringes

16 weeks: 112 syringes

Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution. 8 weeks (8 vials): 24 mL → 3 × 10 mL bottles

12 weeks (12 vials): 36 mL → 4 × 10 mL bottles

16 weeks (16 vials): 48 mL → 5 × 10 mL bottles

Alcohol Swabs: One for the vial stopper + one for the injection site each day. Per week: 14 swabs (2/day)

8 weeks: 112 swabs → recommend 2 × 100‑count boxes

12 weeks: 168 swabs → recommend 2 × 100‑count boxes

16 weeks: 224 swabs → recommend 3 × 100‑count boxes

Product Gallery

Quick Inquiry

Customer Support & Price Inquiry

Send product, purity, quantity, destination and documentation requirements. Quantai will follow up through WhatsApp or email.

Email: kongq687@gmail.com

WhatsAppMia WhatsApp Business QR code

Address: Huangpu District, Guangzhou, China